Clinical Trial Update: In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia [NA]

View source ↗

Summary

A completed human trial evaluating the in vivo effects of a C1-esterase inhibitor on the innate immune response during endotoxemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia
• Multi-organ Dysfunction Syndrome

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: Radboud University Medical Center | Conditions: Endotoxemia, Inflammation | NA | Status: COMPLETED